V ascular risk factors predict cognitive decline and dementia. [1] [2] [3] Coronary artery calcium (CAC) is a subclinical vascular disease and can be viewed as marking biological response to cumulative vascular injuries and may predict dementia independently of baseline vascular risk factors. Only a few longitudinal studies, however, reported on dementia and subclinical vascular disease.
Coronary Artery Calcium and Dementia serious illness, were recruited from 6 US communities in 2000 to 2002. Cognitive inability in the screening interview was an exclusion criterion (an interviewer judged whether the respondent was cognitively able to participate in the study). For this study, we used follow-up and events data through 2013. All participants in the analyses gave informed consent, and the study protocol was approved by the Institutional Review Board at each site.
CAC Score
Detailed methods for computed tomographic (CT) scan technique and interpretation were previously described. 9 Computed tomographic scans were performed twice per participant at baseline and read centrally at the Harbor-University of California, Los Angeles Research and Education Institute to identify and quantify coronary calcium. We analyzed the baseline total Agatston score (CAC score) 10 averaged across the 2 computed tomographic scans. Agreement for the presence of coronary calcium was high (κ statistic 0.90-0.93 between and within readers), and the intraclass correlation coefficient for CAC score between readers was 0.99. 9 
Other Measures at Baseline
Standardized questionnaires were used to obtain information at baseline, including highest level of education attained, possession of health insurance, physical activity, smoking history, and medication usage. Height and weight were measured in light clothing and no shoes. Physical activity level was quantified as average metabolic equivalent minutes per week of moderate or vigorous activity using the MESA Typical Week Physical Activity Survey. 11 Body mass index (BMI) was calculated as weight divided by height squared (kg/ m 2 ). Obesity was defined as body mass index ≥30 kg/m 2 . Seated resting blood pressure was measured 3× with a Dinamap model Pro 100 automated oscillometric sphygmomanometer (Critikon). The average of the last 2 measurements was used in analysis. 12 Total and highdensity lipoprotein cholesterol, triglycerides, and glucose concentrations were measured from blood samples obtained after a 12-hour fast. Non-high-density lipoprotein cholesterol was calculated by subtracting high-density lipoprotein cholesterol from total cholesterol. Diabetes mellitus was defined as fasting glucose >6.99 mmol/L (126 mg/dL) or use of hypoglycemic medication. APOE4 isoforms were estimated from single nucleotide polymorphisms rs429358 and rs741 using the algorithm reported previously. 13 It was categorized here according to carriage of APOE4 as homozygous, heterozygous, or nullizygous (noncarrier).
Ascertainment of Clinical Events
In MESA, telephone interviews inquired about interim hospital admissions and deaths every 9 to 12 months. Copies of death certificates and corresponding International Statistical Classification of Diseases and Related Health Problems, 10th version (ICD10) codes, face sheets and ICD9 codes from hospital records and some outpatient diagnoses were assembled at each center. Medical records were purposed to adjudicate cardiovascular events. An attempt was made to obtain at least ICD coding for each hospitalization or death. If the events were related to MESA outcomes, the full medical records were requested, and the clinic coordinator submitted copies of parts deemed relevant to the MESA adjudication committee for review. CVD-related end points were classified by 2 physicians from the MESA mortality and morbidity review committee.
14 Methodology of identification of incident dementia and its validity was reported elsewhere. 15 In brief, we identified candidate dementia cases using the following diagnosis codes: ICD9: 290, 294, 331.0, 331.1, 331.2, 331.82, 331.83, 331.9, 438.0, and 780.93; ICD10: F00, F01, F03, F04, G30, G31 (excluding G31.2), I69.91, and R41. A physician (A.F.), blinded to ICD codes and CAC status, reviewed available medical records for the potential cases identified with the ICD codes. We excluded those who were judged as likely nondementia from our cases.
We only included those with no missing variables pertinent to analyses (n=6293).
Statistical Analyses
The participants were categorized according to the baseline CAC score of 0, 1 to 400, 401 to 1000, and ≥1001. To test a graded relation of baseline characteristics across CAC categories, P values were obtained with linear regression for continuous and Mantel-Haenszel χ 2 test for categorical variables.
We first calculated crude rates of dementia across CAC categories. Adjusted hazard ratio (HRs) and 95% confidence intervals were obtained by Cox regression models. We treated time of first qualifying dementia ICD code as time of event. On visual inspection of adjusted survival curves, we observed an overall gradient relationship between CAC category and dementia risk. Then, we treated CAC score as continuous using base-2 logarithm of CAC score plus 1 (log2 [CAC+1]) in accordance with previous studies. 16, 17 For minimal adjustment, we adjusted for age (years), sex, and race/ethnicity. For full adjustment, we further adjusted for highest education attained (up to high school/up to associate degree/bachelor's degree or higher), having health insurance (yes/no), physical activity (log-transformed metabolic equivalent min/wk), smoking (current/former/never), obesity (yes/no), systolic blood pressure (mm Hg), non-high-density lipoprotein cholesterol (mg/dL), medication(s) for hypertension or dyslipidemia (yes/no), diabetes mellitus (yes/no), and APOE4 (homo/ hetero/none). There was no evidence against the proportional hazard assumption for the CAC categories and dementia risk based on the Schoenfeld residuals and visual inspection of the log-log curve in the full adjustment model.
In secondary analyses to study mediation of the association, we additionally adjusted for time-dependent stroke or CVD (myocardial infarction, resuscitated cardiac arrest, or stroke) occurring before dementia diagnosis. We also ran models excluding such interim events. In sensitivity analyses, we used a competing risk model using the proportional subdistribution hazards model 18 with otherwise the same set of adjusting covariates. In this model, we treated death without dementia diagnosis as the risk competing with dementia. To address possible residual confounding by age and birth cohort effect, we conducted a model using age as the time scale with stratification by 3 birth cohorts: <1925 (n=626, [age range at baseline, 77-84 years], 1925 to <1935 (n=1688, [67-76 years]), and 1935 or after (n=3979, [45-66 years] ). This model may be preferred when age at event may have a larger effect on the hazard (ie, dementia) than follow-up time period 19 because age is a strong risk factor for dementia and CAC. Finally, we ran the full adjustment model according to the baseline age (<75 versus ≥75 years). The age cutoff was chosen so that number of dementia cases was approximately halved for each age group. Interactions by sex, race/ethnicity, and baseline age (<75 or ≥75 years) on the relation between CAC and dementia were tested by inserting a product term in the full adjustment model. All adjusting covariates except interim stroke and CVD were assessed at baseline.
Because an interaction between atherosclerosis and APOE4 genotype was suggested in some studies, 20, 21 we examined whether the association of CAC with dementia differed by APOE4 status (carrier/ noncarrier) inserting a product term in the full adjustment model.
Statistical significance was at P <0.05 (2-sided P value). SAS software (version 9.4; SAS Institute, Inc, Cary, NC) was used for all statistical analyses.
Results
We analyzed 6293 participants (47.5% men, 12.2% Chinese, 26.1% black, 22.5% Hispanic, and 39.2% white) and observed 271 dementia cases, 173 interim strokes, and 385 interim CVD events during the median follow-up of 12.2 years (interquartile range, 11.6-12.7 years). The proportions with baseline CAC score of 0, 1 to 400, 401 to 1000, and ≥1001 were 49.8% (n=3132), 40.3% (2539), 6.1% (384), and 3.8% (238), respectively. Those with higher baseline CAC tended to be older, white, male, less physically active, former smoker, user of antihypertensive and lipid-lowering medications, having higher systolic blood pressure, and diabetics (Table 1 ). Crude dementia rates in both sexes increased steeply with age (Table  I in the Data Supplement). Table 2 shows mutually adjusted HRs for the covariates in the full adjustment plus interim stroke. Interim stroke had the greatest magnitude of association with dementia risk (HR, 5.66) followed by older age. Male sex, current smoker, and CAC were positively associated with dementia, whereas physical activity was inversely associated. Chinese participants had lower dementia risk than white participants. APOE4 genotype had a graded association with dementia; HRs of heterozygous and homozygous compared with noncarriers were 1.33 and 2.20, respectively. Interim CVD was also strongly associated with dementia (HR, 5.08; Table II in the Data Supplement).
Crude rate ratio of dementia, relative to CAC score zero, for those with CAC score of 1 to 400, 401 to 1000, and ≥1001 were 3.12, 5.05, and 8.44, respectively, (Table 3 ). In the minimal adjustment and the full adjustment models, results were attenuated, but the graded positive trend remained (Table 4) . The HR associated with 1 SD higher log2[CAC+1] (1 SD=3.634, equivalent to multiplying CAC score by 12.4) was 1.24 (95% confidence interval, 1.08-1.41; P=0.002) in the full adjustment model. Further adjustment for interim stroke or the competing risk model attenuated the relation, but the overall association lost statistical significance only in a mediation model, adjusting for interim CVD (P=0.084). The model using age as time scale, stratified by 3 birth cohorts, yielded *Median (25th, 75th percentile) was given as the distribution was skewed. †For physical activity, log-transformed value of (1+MET min/wk) was used to obtain the P value. ‡Observed numbers for each genotype in total sample were consistent with Hardy-Weinberg equilibrium (P=0.212).
similar results to the full adjustment model. In secondary analyses excluding the participants who developed interim stroke or CVD, the associations were decreased but remained significant using log2[CAC+1]. In stratified analysis by baseline age <75 years (n=5388, 117 events) versus ≥75 years (n=905, 154 events), the association was attenuated in the older group, but a positive association remained significant in both age groups with full adjustment. 
Discussion
In this community-based multiethnic cohort sample, we found that baseline CAC was associated with future dementia risk independent of baseline vascular risk factors and APOE4 genotype. Although the positive association was attenuated to nonsignificance by adjustment for interim CVD, it remained significant after excluding interim stroke/CVD. With some inconsistency, 22 vascular risk factors have been shown to predict subsequent cognitive decline or dementia, [1] [2] [3] perhaps depending on when risk factors were measured over the life course, as some risk factors such as blood pressure and smoking habits change over time. CAC, in contrast, is a cumulative, quantitative biomarker of vascular injury. To our knowledge, this is the first population-based study that prospectively showed a positive graded association of CAC with dementia risk not only independent of vascular risk factors and APOE4, but also in the absence of clinical CVD. Our finding is consistent with the conjecture that vascular injury plays an important pathogenetic role in dementia because CAC may correlate well with subclinical vascular changes in the brain. 23, 24 A few longitudinal studies 4, 5, 7 have reported an association of carotid atherosclerosis with dementia. In many of those, only higher levels of IMT (eg, >80th percentile) were associated with (total) dementia with no clear dose-response relation. 4, 5, 7 In longitudinal analysis of a subgroup of the CHS (Cardiovascular Health Study), the participants with CAC score of ≥400 at baseline had higher dementia risk than those with low score of 0 to 10. 6 However, the average age of the participants was much older (80 years), and the sample size was smaller (n=532) than our study.
We observed remarkably elevated dementia risk among those who developed interim stroke or CVD. Exclusion of those participants attenuated the association between CAC and dementia. Certainly, stroke increases the risk of vascular-related 25 Beyond that, our results suggest that overall CVD is a risk factor for dementia, conceivably related to subclinical cerebrovascular changes, which is consistent with the CHS report of elevated dementia risk among those with prevalent CVD, other than stroke. 7 The pathway via clinical stroke to dementia is known to be only the tip of the iceberg. Recent evidence suggests an important role of cerebral small vessel disease, manifested as lacunes, microbleeds, and white matter hyperintensities in magnetic resonance imaging, for both vascular and neurodegenerative dementia. 26, 27 From this perspective, previous studies give insights into potential mechanisms linking CAC and dementia. The AGES (Age, Gene, Environment Susceptibility)-Reykjavik Study, a cross-sectional study in Iceland, for example, reported not only a positive association of CAC with dementia/cognitive performance, but also an association between CAC and cerebral pathologies (infarcts, microbleeds, white matter lesions, and lower brain volume) assessed with brain magnetic resonance imaging. Interestingly, in their analysis, the relation of dementia/cognitive performance to CAC was significantly attenuated after adjustment for those brain findings. 23 Similarly, the Rotterdam study and the CHS reported cross-sectional associations of CAC with (subclinical) brain pathologies and abnormal cognitive status. 24, 28, 29 In our model, adjustment for interim CVD attenuated the association of CAC with dementia to nonsignificance. This may be because those with interim CVD had more advanced atherosclerosis in the brain at the CAC measurement than those without, providing a mechanism for the relationship and attenuating the overall association. Although exclusion of interim events may result in a biased estimate, that estimate is more conservative than in the full adjustment model. Therefore, the existing literature, together with our findings, suggests that CAC indicates the presence of the coexisting brain pathologies that increase dementia risk. 23, 24, 28, 29 MESA previously found a positive association of continuous CAC with dementia risk, one of the multiple outcomes evaluated in that report. 17 Compared with the earlier report, our dementia ascertainment was more thorough and validated, 15 using not only hospital records used in the previous study but also death certificates and more inclusive dementia-defining codes, which enabled us to almost double the number of cases. Other novel findings shown in our study but not in the previous one include a clear dose-response relation of CAC with dementia in multivariable adjustment, including APOE4, and persistent association of CAC with dementia after excluding or adjustment for interim stroke events, supporting the importance of subclinical vascular injury in occurrence of dementia.
APOE4 is an established risk factor for Alzheimer's disease. Effect size of APOE4 carriers observed in our study seems to be weaker than other cohort studies. 30, 31 Because those previous reports studied only on Alzheimer disease, our estimate is likely diluted because of inclusion of other type of †Adjusting covariates in minimal adjustment: age (y), sex, and race (White/Black/Chinese/Hispanic). Full adjustment further included education level (to high school/ to associate degree/bachelor's degree or higher), having health insurance (yes/no), physical activity (MET min/wk, log-transformed), smoking (current/former/never), obesity (yes/no), hypertension (yes/no), medication(s) for hypertension or dyslipidemia (yes/no), systolic blood pressure (mm Hg), non high-density lipoprotein cholesterol (mg/dL), diabetes mellitus (yes/no), APOE ε4 genotype (homo/hetero/none).
‡Interim stroke and interim CVD were treated as time-dependent variables. §In the competing risk model, death without dementia diagnosis was treated as the competing risk to dementia. ‖The results were based on Cox regression model stratified with 3 birth cohorts (1917 to <1925, 1925 to <1935, and thereafter).
dementia. Our results did not support interaction by APOE4 on the association of atherosclerosis (CAC) with dementia in contrast with some, 20, 21 but not all, 4,7 previous studies. This question, therefore, warrants further investigation.
Validity of ICD-Based Code
Because we used ICD codes from hospitalization and death certificate in identifying dementia cases, and given that dementia is a nonprimary event of interest in MESA, we may have missed cases from nonhospitalized and or less advanced dementia (false negatives). 32, 33 Our estimate is, therefore, likely more applicable to advanced cases of dementia. Nevertheless, our findings were generally consistent with other population-based studies that used more clinically oriented case ascertainments (ie, cognitive screening tests on the entire cohort followed by clinical assessment as indicated). 4, 34 In addition, our model found multiple factors associated with dementia, directionally consistent with the current literature: increased risk with current smoking, 35 less physical activity, 35 and APOE4 carriers 35 in a graded fashion. All those findings suggest internal validity of our case identification.
Limitations and Strengths
We were unable to study the association of CAC with major dementia subtypes: Alzheimer and vascular type. These subtypes may be difficult to differentiate as necropsy studies have shown that each neuropathological feature commonly coexists in demented elderly adults. 36, 37 We think that such differentiation is of interest, but not necessarily crucial in examining our hypothesis because vascular injuries have been related not only to vascular-type dementia, but also to Alzheimer types, 4, 5, 7, 38 and these 2 subtypes can be viewed as a continuum (ie, mixed-type dementia).
26,27
Importantly, we are unable to isolate the potential independent contribution of CAC from that of cerebral small vessel disease 26 with which it is known to be related. This does not, however, diminish the important strong predictive value of the CAC measure we demonstrated. An advantage of the ICD-based approach compared with cognitive function testing alone is that the former is based on a clinical diagnosis. Any type of cognitive function test administered at 1× has an inherent limitation, influenced by fluctuation of concentration, and inability to diagnose cognitive decline from their baseline. A strength of our study was verification of cases by review on medical records to minimize false positives.
In conclusion, our study showed a positive graded association between baseline CAC score and future dementia risk independent of baseline vascular risk factors, APOE4 genotype, and interim stroke events in a community-based sample of men and women. The results support the important role of vascular injuries in pathogenesis of dementia, although whether CAC indicates presence of dementia-related pathologies in the brain warrants further investigation. 
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